SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000899140-17-000649
Filing Date
2017-11-06
Accepted
2017-11-06 16:18:52
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 ASIA (HONG KONG) LTDPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G k22678456a.htm SC 13G 145180
2 JOINT FILING AGREEMENT k22678456b.htm EX-99.1 6805
  Complete submission text file 0000899140-17-000649.txt   153638
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87705 | Film No.: 171179683
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G